[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342686-105":59,"doc-detail-342686-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","foxo1-promotes-ovarian-cancer-by-increasing-transcription-and-mettl14-mediated-m6a-modification-of-smc4","FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m6A modification of SMC4","","The transcription factor forkhead box protein O1 (FoxO1) is closely linked to ovarian cancer (OC), but its precise role and molecular mechanisms remain unclear. FoxO1 is highly expressed in clinical OC samples and correlates with poor prognosis. FoxO1 knockdown suppresses OC cell proliferation in vitro and in vivo. Mechanistically, FoxO1 transcriptionally activates SMC4 by binding its promoter and enhances METTL14-dependent m6A methylation on SMC4 coding sequences. TCGA analysis supports positive correlations among FoxO1, SMC4, and METTL14.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/foxo1-promotes-ovarian-cancer-by-increasing-transcription-and-mettl14-mediated-m6a-modification-of-smc4/342686/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/foxo1-promotes-ovarian-cancer-by-increasing-transcription-and-mettl14-mediated-m6a-modification-of-smc4/342686.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What relationship does FoxO1 have with ovarian cancer outcomes?","Question",{"text":113,"@type":114},"FoxO1 is highly expressed in ovarian cancer patient samples and is significantly correlated with poor prognosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does FoxO1 affect ovarian cancer cell growth?",{"text":118,"@type":114},"FoxO1 knockdown inhibits the proliferation of ovarian cancer cells in vitro and in vivo.",{"name":120,"@type":111,"acceptedAnswer":121},"Which molecular pathway links FoxO1 to SMC4 and m6A modification?",{"text":122,"@type":114},"FoxO1 promotes SMC4 transcription by binding to the SMC4 promoter region and increases SMC4 mRNA via METTL14-dependent m6A methylation on its coding sequence.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},342686,1791028910,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","DOI: 10. 1111/cas.16120  \nOR I G I NAL ART I C L E  \nFoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m6A modification of SMC4  \nLiping Tan1,2 | Shuangan Wang1,2 | Shijia Huang3 | Yujuan Tie1,2 | Na Sai1,2 | Yichen Mao1,2 | Shuli Zhao3 | Yayi Hou1,2 | Huan Dou1,2   \n1The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, China  \n2Jiangsu Key Laboratory of Molecular Medicine, Nanjing, China  \n3General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China  \nCorrespondence  \nHuan Dou and Yayi Hou, The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing 210093, China.  \nEmail: [douhuan@nju.edu.cn](douhuan@nju.edu.cn) and[yayihou@nju.edu.cn](yayihou@nju.edu.cn)  \nShuli Zhao, General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.  \nEmail: [shulizhao79@163.com](shulizhao79@163.com)  \nFunding information  \nNational Natural Science Foundation of China, Grant/Award Number: 32070883 and 82173205; Innovative Training Program for Undergraduates of Nanjing University, Grant/Award Number:  \n202310284350Y  \nAbstract  \nThe transcription factor forkhead box protein O1 (FoxO1) is closely related to the occurrence and development of ovarian cancer (OC), however its role and molecular mechanisms remain unclear. Herein, we found that FoxO1 was highly expressed in clinical samples of OC patients and was significantly correlated with poor prognosis. FoxO1 knockdown inhibited the proliferation of OC cells in vitro and in vivo. ChIP-seq combined with GEPIA2 and Kaplan–Meier database analysis showed that structural maintenance of chromosome 4 (SMC4) is a downstream target of FoxO1, and FoxO1 promotes SMC4 transcription by binding to its −1400/−1390 bp promoter. The high expression of SMC4 significantly blocked the tumor inhibition effect of FoxO1 knockdown. Furtherly, FoxO1 increased SMC4 mRNA abundance by transcriptionally activating methyltransferase-like 14 (METTL14) and increasing SMC4 m6A methylationon its coding sequence region. The Cancer Genome Atlas dataset analysis confirmed a significant positive correlation between FoxO1, SMC4, and METTL14 expression in OC. In summary, this study revealed the molecular mechanisms of FoxO1 regulating SMC4 and established a clinical link between the expression of FoxO1/METTL14/ SMC4 in the occurrence of OC, thus providing a potential diagnostic target and therapeutic strategy.  \nK E Y WO R D S  \nFoxO1, m6A modification, METTL14, ovarian cancer progression, SMC4  \n1 | INTRODUCTION  \nOvarian cancer (OC) is one of the three common malignant tumors affecting the female reproductive system. According to available statistics, about 314,000 women worldwide were diagnosed with OC in 2020, and 207,000 died of this disease.1 OC ranks first for the mortality rates among gynecological malignant tumors. Due  \nto the non-specificity of early clinical symptoms and the low efficiency of current OC screening, >75% of patients were in the late stage of clinical diagnosis, with a 5-year survival rate of about 20% . 2,3 The most commonly used method for clinical screening of OC is to detect serum carbohydrate antigen 125 (CA125) level, combined with or without transvaginal ultrasound (TVUS) . Nonetheless, the sensitivity, specificity, and survival benefit of  \nLiping Tan and Shuangan Wang contributed equally to this work.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.  \nCA125 are insufficient for routine screening","cbCainL94yJFzKql","https://ap.wps.com/l/cbCainL94yJFzKql","pdf",8591530,17,"English","# Introduction\n## FoxO1 in ovarian cancer pathogenesis\n## Diagnostic challenges and biomarker needs","[{\"question\":\"What relationship does FoxO1 have with ovarian cancer outcomes?\",\"answer\":\"FoxO1 is highly expressed in ovarian cancer patient samples and is significantly correlated with poor prognosis.\"},{\"question\":\"How does FoxO1 affect ovarian cancer cell growth?\",\"answer\":\"FoxO1 knockdown inhibits the proliferation of ovarian cancer cells in vitro and in vivo.\"},{\"question\":\"Which molecular pathway links FoxO1 to SMC4 and m6A modification?\",\"answer\":\"FoxO1 promotes SMC4 transcription by binding to the SMC4 promoter region and increases SMC4 mRNA via METTL14-dependent m6A methylation on its coding sequence.\"}]","FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m6A modification of SMC4 | PDF",1790047724,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/114b38aed021cf9204d93c2a844825d6.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68f026c94a3b5e792de632f397c9395f.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bbd0bc13a75c349aa0cf03d2ee7e70f.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a03122dbb1dcb2d8e5daed2178bfeb6.webp",980,1287]